LOVE TED W

CIK 000118891916 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001188919

Recent Transactions

50 trades

Award
Structure Therapeutics Inc.$GPCR
Share Option (right to buy)
2025-06-23+51,804→ 51,804 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-05-13+7,614→ 53,848 total
Award
GILEAD SCIENCES, INC.$GILD
Common Stock
2025-05-07+1,516→ 4,338 total
Award
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2025-05-07+6,809→ 6,809 total
Award
Structure Therapeutics Inc.$GPCR
Share Option (right to buy)
2024-06-25+33,595→ 33,595 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2024-06-07+9,293→ 46,234 total
Award
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2024-05-08+12,648→ 12,648 total
Award
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-05-08+2,310→ 2,822 total
Award
GILEAD SCIENCES, INC.$GILD
Non-qualified Stock Option (Right to Buy)
2024-02-02+2,996→ 2,996 total
Award
GILEAD SCIENCES, INC.$GILD
Common Stock
2024-02-02+512→ 512 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−3,676→ 0 total
Disposition to Issuer
Seagen Inc.
Restricted Stock Units
2023-12-14−2,044→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−4,460→ 0 total
Disposition to Issuer
Seagen Inc.
Common Stock
2023-12-14$229.00/sh−4,255→ 0 total
Disposition to Issuer
Seagen Inc.
Stock Options (Right to Buy)
2023-12-14−3,462→ 0 total
Disposition to Issuer
Seagen Inc.
Restricted Stock Units
2023-12-14−449→ 0 total
Award
Structure Therapeutics Inc.$GPCR
Stock option (right to buy)
2023-08-03+75,000→ 75,000 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2023-06-23+7,747→ 36,941 total
Award
Seagen Inc.
Common Stock
2023-05-31+2,044→ 6,748 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−118,090→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−145,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−2,500→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−119,650→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−63,768→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−119,650→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−26,865→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−2,500→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−114,190→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−47,223→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−114,515→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−122,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−132,433→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−109,116→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−141,400→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−11,250→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−576,318→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−102,000→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-27$16.40/sh+18,291→ 576,318 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-09-27−18,291→ 114,515 total
Gift
Global Blood Therapeutics, Inc.
Common Stock
2022-09-13−35,300→ 558,027 total
Gift
Global Blood Therapeutics, Inc.
Common Stock
2022-09-13+17,650→ 119,650 total
Gift
Global Blood Therapeutics, Inc.
Common Stock
2022-09-13+17,650→ 119,650 total
Gift
Global Blood Therapeutics, Inc.
Common Stock
2022-09-09−221,200→ 593,327 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−9,109→ 63,768 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-09-01−9,444→ 47,223 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01$68.15/sh−9,200→ 814,527 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+9,109→ 823,727 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-09-01+9,444→ 814,618 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2022-08-01$32.40/sh−10,018→ 805,174 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-08-01−8,955→ 26,865 total

Companies

Recent Filings

Address

C/O AFFYMAX, INC. 4001 MIRANDA AVE.

PALO ALTO, CA, 94304

View on SEC.gov